logo
Plus   Neg
Share
Email

Gilead Announces NDA Submission For Filgotinib In Japan - Quick Facts

Gilead Sciences, Inc. (GILD) has submitted a New Drug Application for filgotinib, an investigational, oral, selective JAK1 inhibitor for the treatment of adults with rheumatoid arthritis, to the Japanese Ministry of Health, Labor and Welfare. The NDA is supported by data from the Phase 3 FINCH clinical trial program.

"This new drug application is an important milestone as we continue to expand Gilead's presence in Japan to now also include inflammation," said Luc Hermans, President and Representative Director, Gilead Sciences, K.K.

Filgotinib is an investigational agent and is not approved anywhere globally.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Hongkong Sun Rise Trading Ltd. has recalled about 151,400 units of Kobalt Cordless Electric chainsaws and about 106,520 units of Kobalt Cordless Electric pole saws for possible laceration hazard, according to two separate statements issued by the U.S. Consumer Product Safety Commission. These include 1,400 chainsaws and 120 pole saws sold in Canada. Branded food company Hormel Foods Corp. (HRL) announced Friday that its Hormel Black Label Breakfast Food Truck will hit the road with free sample event of the popular brand's new Hormel Black Label Oven-Baked Egg Bites. The samples come in three variants - with Bacon, with Chorizo and with Bacon and... United Airlines has rolled out an interactive online "Map Search" feature for its customers in collaboration with search giant Google. The new feature is powered by Google Flight Search Enterprise Technology. United is claimed to be the first airline in the U.S. to add this feature. The new feature, available on United.com, allows customers to easily search, compare and purchase flight tickets.
Follow RTT